首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 (2S,5S,8S,11S,14S)-2-氨基-14-[((S)-1-[((S)-5-氨基-1-({2-[(S)-2-({(S)-1-[((S)-1-[(S)-2-{[(6S,9S,12S,15S,18S,27S)-1-氨基-9,15,18-三苄基-6-[(S)-2-({(S)-1-[((S)-1,4-二氨基-1,4-二氧代丁-2-基)氨基]-5-胍基-1-氧代戊-2-基}氨基甲酰基)吡咯烷-1-羰基]-28-羟基-1-亚氨基-12-异丁基-8,11,14,17,20,23,26-七氧代-2,7,10,13,16,19,22,25-八氮杂二十八烷-27-基]氨基甲酰基}吡咯烷-1-基]-1-氧代丙-2-基)氨基]-3-甲基-1-氧代丁-2-基}氨基甲酰基)吡咯烷-1-基]-2-氧代乙基)氨基]-1,5-二氧代戊-2-基)氨基]-3-(4-羟基苯基)-1-氧代丙-2-基]氨基甲酰基)-11-(2-氨基-2-氧代乙基)-5-(4-氨基丁基)-1-(4-羟基苯基)-8-异丙基-3,6,9,12-四氧代-4,7,10,13-四氮杂十七烷-17-酸

(2S,5S,8S,11S,14S)-2-氨基-14-[((S)-1-[((S)-5-氨基-1-({2-[(S)-2-({(S)-1-[((S)-1-[(S)-2-{[(6S,9S,12S,15S,18S,27S)-1-氨基-9,15,18-三苄基-6-[(S)-2-({(S)-1-[((S)-1,4-二氨基-1,4-二氧代丁-2-基)氨基]-5-胍基-1-氧代戊-2-基}氨基甲酰基)吡咯烷-1-羰基]-28-羟基-1-亚氨基-12-异丁基-8,11,14,17,20,23,26-七氧代-2,7,10,13,16,19,22,25-八氮杂二十八烷-27-基]氨基甲酰基}吡咯烷-1-基]-1-氧代丙-2-基)氨基]-3-甲基-1-氧代丁-2-基}氨基甲酰基)吡咯烷-1-基]-2-氧代乙基)氨基]-1,5-二氧代戊-2-基)氨基]-3-(4-羟基苯基)-1-氧代丙-2-基]氨基甲酰基)-11-(2-氨基-2-氧代乙基)-5-(4-氨基丁基)-1-(4-羟基苯基)-8-异丙基-3,6,9,12-四氧代-4,7,10,13-四氮杂十七烷-17-酸

(2S,5S,8S,11S,14S)-2-amino-14-(((S)-1-(((S)-5-amino-1-((2-((S)-2-(((S)-1-(((S)-1-((S)-2-(((6S,9S,12S,15S,18S,27S)-1-amino-9,15,18-tribenzyl-6-((S)-2-(((S)-1-(((S)-1,4-diamino-1,4-dioxobutan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)-28-hydroxy-1-imino-12-isobutyl-8,11,14,17,20,23,26-heptaoxo-2,7,10,13,16,19,22,25-octaazaoctacosan-27-yl)carbamoyl)pyrrolidin-1-yl)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamoyl)pyrrolidin-1-yl)-2-oxoethyl)amino)-1,5-dioxopentan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)carbamoyl)-11-(2-amino-2-oxoethyl)-5-(4-aminobutyl)-1-(4-hydroxyphenyl)-8-isopropyl-3,6,9,12-tetraoxo-4,7,10,13-tetraazaheptadecan-17-oic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 95% 询价
- +
5mg 95% 询价
- +
10mg 95% 询价
- +
25mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

117505-80-3

中文名称

(2S,5S,8S,11S,14S)-2-氨基-14-[((S)-1-[((S)-5-氨基-1-({2-[(S)-2-({(S)-1-[((S)-1-[(S)-2-{[(6S,9S,12S,15S,18S,27S)-1-氨基-9,15,18-三苄基-6-[(S)-2-({(S)-1-[((S)-1,4-二氨基-1,4-二氧代丁-2-基)氨基]-5-胍基-1-氧代戊-2-基}氨基甲酰基)吡咯烷-1-羰基]-28-羟基-1-亚氨基-12-异丁基-8,11,14,17,20,23,26-七氧代-2,7,10,13,16,19,22,25-八氮杂二十八烷-27-基]氨基甲酰基}吡咯烷-1-基]-1-氧代丙-2-基)氨基]-3-甲基-1-氧代丁-2-基}氨基甲酰基)吡咯烷-1-基]-2-氧代乙基)氨基]-1,5-二氧代戊-2-基)氨基]-3-(4-羟基苯基)-1-氧代丙-2-基]氨基甲酰基)-11-(2-氨基-2-氧代乙基)-5-(4-氨基丁基)-1-(4-羟基苯基)-8-异丙基-3,6,9,12-四氧代-4,7,10,13-四氮杂十七烷-17-酸

英文名称

(2S,5S,8S,11S,14S)-2-amino-14-(((S)-1-(((S)-5-amino-1-((2-((S)-2-(((S)-1-(((S)-1-((S)-2-(((6S,9S,12S,15S,18S,27S)-1-amino-9,15,18-tribenzyl-6-((S)-2-(((S)-1-(((S)-1,4-diamino-1,4-dioxobutan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)-28-hydroxy-1-imino-12-isobutyl-8,11,14,17,20,23,26-heptaoxo-2,7,10,13,16,19,22,25-octaazaoctacosan-27-yl)carbamoyl)pyrrolidin-1-yl)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamoyl)pyrrolidin-1-yl)-2-oxoethyl)amino)-1,5-dioxopentan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)carbamoyl)-11-(2-amino-2-oxoethyl)-5-(4-aminobutyl)-1-(4-hydroxyphenyl)-8-isopropyl-3,6,9,12-tetraoxo-4,7,10,13-tetraazaheptadecan-17-oic acid

别名

neuromedin U-23;NEUROMEDIN U (RAT);NMU-23 (RAT);NMU, RAT;YKVNEYQGPVAPSGGFFLFRPRN-NH2;TYR-LYS-VAL-ASN-GLU-TYR-GLN-GLY-PRO-VAL-ALA-PRO-SER-GLY-GLY-PHE-PHE-LEU-PHE-ARG-PRO-ARG-ASN-NH2;H-TYR-LYS-VAL-ASN-GLU-TYR-GLN-GLY-PRO-VAL-ALA-PRO-SER-GLY-GLY-PHE-PHE-LEU-PHE-ARG-PRO-ARG-ASN-NH2;neuromedin U

标准英文名

(2S,5S,8S,11S,14S)-2-amino-14-(((S)-1-(((S)-5-amino-1-((2-((S)-2-(((S)-1-(((S)-1-((S)-2-(((6S,9S,12S,15S,18S,27S)-1-amino-9,15,18-tribenzyl-6-((S)-2-(((S)-1-(((S)-1,4-diamino-1,4-dioxobutan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)carbamoyl)pyrrolidine-1-carbonyl)-28-hydroxy-1-imino-12-isobutyl-8,11,14,17,20,23,26-heptaoxo-2,7,10,13,16,19,22,25-octaazaoctacosan-27-yl)carbamoyl)pyrrolidin-1-yl)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamoyl)pyrrolidin-1-yl)-2-oxoethyl)amino)-1,5-dioxopentan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)carbamoyl)-11-(2-amino-2-oxoethyl)-5-(4-aminobutyl)-1-(4-hydroxyphenyl)-8-isopropyl-3,6,9,12-tetraoxo-4,7,10,13-tetraazaheptadecan-17-oic acid

分子式

C124H180N34O31

分子量

2643.01

精确分子量

2641.36

SMILES

CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(C)C)C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O

标准SMILES

C[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC1C=CC(O)=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1C=CC(O)=CC=1)C(C)C)C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(N)=O

用途

Neuromedin U-23 (rat) is used as a ligand in an electrochemiluminescent (ECL) binding assay to study the human NMUR2 receptor; it is employed to screen large compound libraries for NMUR2 antagonists or modulators by displacing its binding to NMUR2; it serves as a tool for investigating NMUR2-mediated physiological processes such as energy balance, stress response, and nociception.

InChIKey

YYDRKWCPVLDJJD-XOXVDEAXSA-N

安全信息

SureRoute逆合成路线

1.  117505-80-3 逆合成路线 1

—
—
ACSDZD126
117505-80-3
来源: SureRoute

2.  117505-80-3 逆合成路线 2

—
—
ACSDZD126
117505-80-3
来源: SureRoute

3.  117505-80-3 逆合成路线 3

—
—
ACSDZD126
117505-80-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手